Contents
Download PDF
pdf Download XML
460 Views
119 Downloads
Share this article
Research Article | Volume 5 Issue 1 (Jan-June, 2025) | Pages 1 - 2
Shifting Epidemiological Profile of Colorectal Cancer Patients: Global and Indian Perspective
 ,
 ,
1
MS General Surgery, Drpgmc Tanda, India
Under a Creative Commons license
Open Access
Received
Feb. 24, 2025
Revised
March 3, 2025
Accepted
March 24, 2025
Published
April 5, 2025
Abstract

Colorectal cancer (CRC) remains a major global health burden, ranking as the third most commonly diagnosed malignancy in men and the second in women. Despite improvements in screening and treatment, CRC continues to cause substantial morbidity and mortality, especially in developing nations. This article discusses the worldwide and Indian scenario, epidemiological trends, survival challenges, and the need for better clinicopathological profiling to enhance outcomes.

Keywords
INTRODUCTION

Colorectal cancer (CRC) is a malignancy of the gastrointestinal tract with high worldwide prevalence, responsible for significant patient suffering, treatment costs, and burden on healthcare systems. It is the third most common cancer in men and the second most common in women globally [1]. Almost 60% of CRC cases occur in developed regions, with incidence rates varying almost tenfold worldwide. Australia, New Zealand, and Western Europe report the highest rates, while Africa and South-Central Asia observe the lowest [1].

 

Global and Regional Distribution

The global burden of CRC highlights significant geographical disparities. In developed countries, higher incidence rates are attributed to dietary patterns, obesity, and sedentary lifestyles. In high-incidence regions, approximately 25% of CRCs involve the rectum, with rectal cancers more common in men (30%) compared to women (21%) [2]. Lifetime risk of CRC is approximately 5-6% in the Western world, with more than 50% of individuals affected by the age of 70, reflecting its public health significance [3].

 

Notably, racial and ethnic variations have been observed. African Americans in the United States exhibit higher incidence rates compared to Caucasians, while Asian Americans, Native Americans, and Hispanic populations demonstrate comparatively lower rates (4). Ashkenazi Jews are known to have a slightly increased genetic predisposition to CRC [4].

 

Colorectal Cancer in India

India’s age-standardized rate (ASR) for CRC is relatively low, at 7.2 per 100,000 males and 5.1 per 100,000 females [5]. However, given India’s massive population, the absolute number of CRC cases remains significant. CRC accounts for the seventh most common cancer in India, with 65,358 new cases reported in 2021 (18). Unlike Western countries, where CRC primarily affects the 


 

elderly, India reports a higher proportion of younger patients, especially those under 50 years.

 

A major concern is the dismal five-year survival rate, which remains below 40% (6). Data from the CONCORDE-2 study revealed that survival rates are stagnant or even worsening in certain Indian registries, indicating serious gaps in timely diagnosis and access to effective treatments [6].

 

Shifts in Epidemiology

Globally, while CRC incidence is stabilizing or declining in some developed countries due to effective screening programs, it is rising rapidly in developing economies, including parts of Asia. Japan, South Korea, and Singapore have witnessed steep increases, correlating with urbanization and Westernized lifestyles [13]. Within India, while urban areas show a modest increase in colon cancer cases, rural populations demonstrate disproportionately higher rates of rectal cancers [18].

 

This variation may be attributed to different dietary patterns, physical inactivity, and healthcare access. Alarmingly, age-sex adjusted rates of CRC in India increased by 20.6% between 2004 and 2014, with a steeper rise among younger adults under 50 years [18].

 

Challenges in the Indian Context

Several challenges impede CRC management in India. Limited awareness, delayed presentation, inadequate screening infrastructure, and high treatment costs contribute to poor outcomes. Late-stage presentation remains common, with over 50% of patients diagnosed at Stage III or IV [3, 18]. 

 

Compounding these issues is the limited availability of advanced diagnostic imaging, genetic testing, and personalized therapies. Rural populations, in particular, suffer from significant disparities in healthcare access, exacerbating the burden.

CONCLUSION

Colorectal cancer is a rising concern globally and in India. Differences in demographic profiles, tumor locations, and  survival outcomes highlight the urgent need for comprehensive clinicopathological profiling. Systematic national screening programs, public education campaigns, better access to healthcare services, and more robust cancer registries are crucial for improving survival rates in India.

REFERENCE
  1. Bray, F., et al. "Global Cancer Statistics 2018: GLOBOCAN Estimates." CA: A Cancer Journal for Clinicians, vol. 68, no. 6, 2018, pp. 394–424.

  2. Arnold, M., et al. "Global Patterns and Trends in Colorectal Cancer Incidence and Mortality." Gut, vol. 66, no. 4, 2017, pp. 683–691.

  3. Siegel, R.L., et al. "Colorectal Cancer Statistics, 2020." CA: A Cancer Journal for Clinicians, vol. 70, no. 3, 2020, pp. 145–164.

  4. Murphy, C.C., et al. "Racial Disparities in Incidence of Young-Onset Colorectal Cancer." JAMA Surgery, vol. 155, no. 6, 2020, pp. 524–527.

  5. Global Burden of Disease Cancer Collaboration. "Global Burden of Colorectal Cancer." The Lancet Oncology, vol. 20, no. 7, 2019, pp. 913–933.

  6. Allemani, C., et al. "CONCORD-2: Worldwide Comparison of Cancer Survival." The Lancet, vol. 385, no. 9972, 2015, pp. 977–1010.

  7. Center, M.M., et al. "International Trends in Colorectal Cancer Incidence Rates." Cancer Epidemiology Biomarkers & Prevention, vol. 18, no. 6, 2009, pp. 1688–1694

  8. Ferlay, J., et al. "GLOBOCAN 2018: Cancer Incidence and Mortality Worldwide." International Journal of Cancer, vol. 144, no. 8, 2019, pp. 1941–1953.

  9. Sung, H., et al. "Global Cancer Statistics 2020: GLOBOCAN Estimates." CA: A Cancer Journal for Clinicians, vol. 71, no. 3, 2021, pp. 209–249.

  10. Douaiher, J., et al. "Colorectal Cancer: A Multidisciplinary Overview." Surgical Clinics of North America, vol. 97, no. 3, 2017, pp. 631–646.

Recommended Articles
Research Article
Video-Assisted Thoracoscopic Surgery (VATS) with Mini-Thoracotomy for Management of Giant Posterior Hepatic Hydatid Cysts in Segments VI and VII: A Case Report
...
Published: 18/04/2026
Download PDF
Research Article
Advantages of Two Clips Laparoscopic Cholecystectomy (TCLC) and Conventional Laparoscopic Cholecystectomy (CLC): A Comparative Study
...
Published: 10/01/2022
Download PDF
Research Article
Bladder Brilliance: Unveiling the Tapestry of Knowledge on Bladder Cancer in District Kangra, Himachal Pradesh
...
Published: 08/12/2023
Download PDF
Research Article
Shouldering the Pain: Public Knowledge Assessment of Rotator Cuff Injuries in Himachal Pradesh
...
Published: 30/07/2024
Download PDF
Chat on WhatsApp
Flowbite Logo
PO Box 101, Nakuru
Kenya.
Email: office@iarconsortium.org

Editorial Office:
J.L Bhavan, Near Radison Blu Hotel,
Jalukbari, Guwahati-India
Useful Links
Order Hard Copy
Privacy policy
Terms and Conditions
Refund Policy
Shipping Policy
Others
About Us
Team Members
Contact Us
Online Payments
Join as Editor
Join as Reviewer
Subscribe to our Newsletter
+91 60029-93949
Follow us
MOST SEARCHED KEYWORDS
Copyright © iARCON International LLP . All Rights Reserved.